The Multifunctional Role and Therapeutic Potential of HO-1 in the Vascular Endothelium
Authors:
- 10 April 2014
- journal article
- review article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 20 (11) , 1789-1809
Abstract
Significance: Heme oxygenases (HO-1 and HO-2) catalyze the degradation of the pro-oxidant heme into carbon monoxide (CO), iron, and biliverdin, which is subsequently converted to bilirubin. In the vasculature, particular interest has focused on antioxidant and anti-inflammatory properties of the inducible HO-1 isoform in the vascular endothelium. This review will present evidence that illustrates the potential therapeutic significance of HO-1 and its products, with special emphasis placed on their beneficial effects on the endothelium in vascular diseases. Recent Advances: The understanding of the molecular basis for the regulation and functions of HO-1 has led to the identification of a variety of drugs that increase HO-1 activity in the vascular endothelium. Moreover, therapeutic delivery of HO-1 products CO, biliverdin, and bilirubin has been shown to have favorable effects, notably on endothelial cells and in animal models of vascular disease. Critical Issues: To date, mechanistic data identifying the downstream target genes utilized by HO-1 and its products to exert their actions remain relatively sparse. Likewise, studies in man to investigate the efficacy of therapeutics known to induce HO-1 or the consequences of the tissue-specific delivery of CO or biliverdin/bilirubin are rarely performed. Future Directions: Based on the promising in vivo data from animal models, clinical trials to explore the safety and efficacy of the therapeutic induction of HO-1 and the delivery of its products should now be pursued further, targeting, for example, patients with severe atherosclerotic disease, ischemic limbs, restenosis injury, or at high risk of organ rejection. Antioxid. Redox Signal. 20, 1789–1809.Keywords
This publication has 195 references indexed in Scilit:
- Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairmentFree Radical Biology and Medicine, 2012
- Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in miceFree Radical Biology and Medicine, 2011
- Heme Oxygenase-1/Carbon Monoxide Induces Vascular Endothelial Growth Factor Expression via p38 Kinase-dependent Activation of Sp1Journal of Biological Chemistry, 2011
- Carbon Monoxide Promotes VEGF Expression by Increasing HIF-1α Protein Level via Two Distinct Mechanisms, Translational Activation and Stabilization of HIF-1α ProteinJournal of Biological Chemistry, 2010
- Astrocyte‐derived glutathione attenuates hemin‐induced apoptosis in cerebral microvascular cellsGlia, 2010
- Limited Role for the Bilirubin-Biliverdin Redox Amplification Cycle in the Cellular Antioxidant Protection by Biliverdin ReductaseJournal of Biological Chemistry, 2009
- Induction of the Cytoprotective Enzyme Heme Oxygenase-1 by Statins Is Enhanced in Vascular Endothelium Exposed to Laminar Shear Stress and Impaired by Disturbed FlowJournal of Biological Chemistry, 2009
- Carbon monoxide donors or heme oxygenase-1 (HO-1) overexpression blocks interleukin-18-mediated NF-κB–PTEN-dependent human cardiac endothelial cell deathFree Radical Biology and Medicine, 2008
- Stromal cell–derived factor 1 promotes angiogenesis via a heme oxygenase 1–dependent mechanismJournal of Experimental Medicine, 2007
- Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavengingJournal of Experimental Medicine, 2006